Press Releases
With an estimated 42 million adults in the United States suffering from chronic neck and back pain every year, the development of evidence based treatment options, including spinal implants and surgical techniques, would not have been possible without the collaboration between spine surgeons and medical device companies.
My experience as a clinician, researcher, marketer, and product developer have taught me:
“We Never Know How Far Reaching Something We May Think, Say, or Do Today,
May Affect The Lives of Millions of People Tomorrow“
Taking Action to Reduce Post-Operative Surgical Infection
October 20, 2016
“Patient safety is our #1 priority. While multiple factors could contribute to post-operative infection, the authors published data on spinal implants previously assumed sterile and later found to be contaminated,” reports Dr. Robert Wertz, V.P. New Product Development at Nexxt Spine. “We have recently completed certification and validation of our ISO 7, Class 10,000 Cleanroom and will launch our pre-packaged sterile implant initiative parallel to the anticipated FDA clearance of Nexxt Matrixx, a 3-D printed, porous, titanium line of intervertebral spacers used in spine fusion procedures.”
Major Manufacturing Milestones
October 13, 2016
Dr. Robert Wertz, Director of New Product Development, stated “As our new product development efforts and commitment to on-going improvements to legacy products provide the foundation for growth within the marketplace, our process improvement initiatives have tremendously decreased the time from surgeon input to product delivery, creating a solid foundation for exponential future growth.”
Development of NanoMatrixx: a Porous Bioactive Titanium Material
October 12, 2015
According to Dr. Robert L. Wertz, Director of New Product Development, “A glimpse inside of the NanoMatrixx material reveals its uniform 3-dimensional cellular architecture with a consistent 70% porosity. The cubical shaped scaffold provides an optimal biomechanical and biological environment for uninterrupted blood flow. Every surface of the NanoMatrixx material exhibits a micro and nanotextured topography that’s designed to elicit a superior osteogenic response…”
Launch of the TD Elite Guide System
November 16, 2015
According to Dr. Robert L. Wertz, Vice President of New Product Development, “The innovative Struxxure TD Elite Guides simplify the ACDF procedure and provide the framework for a shorter plate to be used which in turn increases the distance to the adjacent disc level wherein studies report a reduction in the risk of developing postoperative degenerative changes, including ALO.”
First Clinical Use of the Inertia MIS Percutaneous Pedicle Screw System
September 8, 2014
“The first clinical use of the Inertia Percutaneous MIS Pedicle Screw System represents a major milestone in the evolution of Nexxt Spine’s capabilities,” stated Dr. Robert L. Wertz, Director of New Product Development.
Full Market Release of Struxxure Anterior Cervical Plating System
May 1, 2015
“Since our inception, we’ve been dedicated to increasing procedural efficiency and patient outcomes through development of innovative products to treat painful and debilitating spinal pathologies”, stated Dr. Robert L. Wertz, Director of New Product Development.
Launch of the Facet Fixx™ Screw System
October 29, 2013
“Trends within the spine market call for less invasive procedures that are simple, reliable and reproducible. Facet Fixx is the latest addition to our Exxpress™ MIS Technology portfolio and is designed to address this growing market demand, while maintaining a focus on streamlined procedural efficiency and positive clinical outcomes.” states Dr. Robert L. Wertz, Director of New Product Development at Nexxt Spine.
Completion of New Headquarters and State of the Art Manufacturing Facility
April 1, 2013
“The healthcare industry’s response to our BUY DIRECT implant purchasing model has been overwhelming” relayed Dr. Robert Wertz, Director, New Product Development. “Nexxt Spine offers the highest quality orthopedic implants hospitals expect at prices the current healthcare environment demands.”